ADI
56
-3
MCHP
42
-5
MNST
52
2
COST
51
-3
SBUX
41
-3
AMAT
49
-3
TJX
50
2
CNX
76
5
WYNN
34
-3
SE
65
4
NWL
32
-3
DOV
63
-6
HBI
59
-2
PSX
42
3
AEP
59
-3
EXPE
74
2
NFLX
55
-3
PNR
72
-2
MSFT
54
-3
AVB
65
-2
ADI
56
-3
MCHP
42
-5
MNST
52
2
COST
51
-3
SBUX
41
-3
AMAT
49
-3
TJX
50
2
CNX
76
5
WYNN
34
-3
SE
65
4
NWL
32
-3
DOV
63
-6
HBI
59
-2
PSX
42
3
AEP
59
-3
EXPE
74
2
NFLX
55
-3
PNR
72
-2
MSFT
54
-3
AVB
65
-2
Financhill
Back

Lyell Immunopharma Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

LYEL
Lyell Immunopharma

Last Price:
1.57
Seasonality Move:
-32.08%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Lyell Immunopharma Price Quote

$1.57
+0.21 (+15.44%)
(Updated: September 19, 2024 at 6:55 PM ET)

Lyell Immunopharma Key Stats

Sell
25
Lyell Immunopharma (LYEL) is a Sell
Day range:
$1.31 - $1.43
52-week range:
$1.09 - $3.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6,382.99
P/B ratio:
0.61%
Volume:
628.2K
Avg. volume:
579.5K
1-year change:
-16.05%
Market cap:
$348.2M
Revenue:
$130K
EPS:
$-0.82

How Much Does Lyell Immunopharma Make?

Is Lyell Immunopharma Growing As A Company?

  • What Is Lyell Immunopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.52%
  • What Is Lyell Immunopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lyell Immunopharma Stock Price Performance

What Is Lyell Immunopharma 52-Week High & Low?

Lyell Immunopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lyell Immunopharma?

Is Lyell Immunopharma Cash Flow Positive?

  • What Is LYEL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$158.4M
  • What Is Lyell Immunopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.5M
  • What Is Lyell Immunopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $66M

Lyell Immunopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    LYEL return on invested capital is -32.26%
  • What Is Lyell Immunopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -28.19%
  • What Is LYEL Return On Equity?
    ROE is a measure of profitability and is -32.26%

Lyell Immunopharma Earnings Date & Stock Price

Lyell Immunopharma Competitors

  • Who Are Lyell Immunopharma's Competitors?
    Below is a list of companies who compete with Lyell Immunopharma or are related in some way:
    • iBio Inc (IBIO)
    • Marinus Pharmaceuticals Inc (MRNS)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Ocular Therapeutix Inc (OCUL)
    • Palatin Technologies Inc (PTN)

Lyell Immunopharma Dividend Yield

Lyell Immunopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -51.85% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 3.67
Upside from Last Price: 169.61%

Major Shareholders

  • How many LYEL shares are owned by institutional investors?
    168.4M LYEL shares are owned by institutional investors
  • How many LYEL shares are owned by insiders?
    8.1M LYEL shares are owned by insiders